Active, not recruitingNCT06448208

Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

Studying Neuroendocrine neoplasm

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Memorial Sloan Kettering Cancer Center
Principal Investigator
Lisa Bodei, MD, PhD
Memorial Sloan Kettering Cancer Center
Intervention
positron emission tomography (PET) scans(diagnostic_test)
Enrollment
11 target
Eligibility
18 years · All sexes
Timeline
2024 – 2026

Study locations (1)

Collaborators

NeuroEndocrine Tumor Research Foundation (NETRF)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06448208 on ClinicalTrials.gov

Other trials for Neuroendocrine neoplasm

Additional recruiting or active studies for the same condition.

See all trials for Neuroendocrine neoplasm →

← Back to all trials